JABFM
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of the American Board of Family Medicine 21 (5): 392-397 (2008)
DOI: 10.3122/jabfm.2008.05.070101
© 2008 American Board of Family Medicine
This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrow Rapid Responses: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rush, W. A.
Right arrow Articles by O'Connor, P. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Rush, W. A.
Right arrow Articles by O'Connor, P. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Depression in Patients with Diabetes: Does It Impact Clinical Goals?

William A. Rush, PhD, Robin R. Whitebird, PhD, Monica R. Rush, BS, Leif I. Solberg, MD and Patrick J. O'Connor, MD, MPH

From the Health Partners Research Foundation, Minneapolis, Minnesota

Correspondence: Corresponding author: William A. Rush, PhD, HealthPartners Research Foundation, PO Box 1524, MS 21111R, Minneapolis, MN 55440-1524 (E-mail: Bill.A.Rush{at}healthpartners.com)

Introduction: To examine whether depressive symptoms are associated with achievement of recommended goals for control of glucose, lipids, and blood pressure among patients with diabetes.

Methods: We used a prospective cohort study of 1223 adults with diabetes that obtained self-reported depression symptoms from a survey. Medication use was obtained from claims data, and pharmacy and clinical data were obtained by manual review of paper medical records.

Results: Diabetes patients with depression symptoms were less likely to be at their glucose goal (43% vs 50%; P = .0176) but more likely to be at their blood pressure goal (57% vs 51%; P = .0435). The association between lipids and depression symptoms was related to a lower rate for low-density lipoprotein testing (56% vs 68%; P < .0001). Treatment with antidepressants resulted in a greater percentage achieving glucose and blood pressure goals but not lipid goals.

Conclusions: Depression seems to have a variable impact on achieving these clinical goals, perhaps because the goals have differing measurement logistics and biological profiles. Further research is needed to learn whether better treatment of depressive symptoms leads to improvements in meeting diabetes clinical goals.



Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Am Board Fam MedHome page
M. A. Bowman, A. V. Neale, and P. Lupo
The Medical Home, Health Services, and Clinical Family Medicine Research
J Am Board Fam Med, September 1, 2008; 21(5): 367 - 369.
[Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Board of Family Medicine.